BSE NSE
Your Result on : Company News Details
Solara Active Pharma Sciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
541540
ISIN Demat
INE624Z01016
Book Value (Rs)
302.0706427
NSE Symbol
SOLARA
Divident Yield %
0
Market Cap
(Rs In Cr.)
2,935
P/E (TTM)
0
EPS (TTM)
0
Face Value
(Rs)
10
Back
Solara Active Pharma Sciences reports consolidated net loss of Rs 2.10 crore in the March 2025 quarter
15-May-25   Hrs IST

Net Loss of Solara Active Pharma Sciences reported to Rs 2.10 crore in the quarter ended March 2025 as against net loss of Rs 255.34 crore during the previous quarter ended March 2024. Sales declined 8.82% to Rs 273.01 crore in the quarter ended March 2025 as against Rs 299.43 crore during the previous quarter ended March 2024.

For the full year,net profit reported to Rs 0.54 crore in the year ended March 2025 as against net loss of Rs 567.39 crore during the previous year ended March 2024. Sales declined 0.40% to Rs 1283.76 crore in the year ended March 2025 as against Rs 1288.92 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales273.01299.43 -9 1283.761288.92 0
OPM %16.623.26 -16.07-7.38 -
PBDT22.20-19.23 LP 99.79-194.92 LP
PBT-2.10-44.48 95 0.54-298.25 LP
NP-2.10-255.34 99 0.54-567.39 LP

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)